[Effects of bencyclane on blood perfusion of the limbs].
D000328:Adult; D000368:Aged; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D001776:Blood Circulation Time; D001783:Blood Flow Velocity; D001794:Blood Pressure; D003508:Cycloheptanes / Q000494:pharmacology* / Q000627:therapeutic use; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004285:Dogs; D005121:Extremities / Q000098:blood supply*; D005260:Female; D005263:Femoral Artery; D005650:Fumarates / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008209:Lymphedema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000188:drug therapy; D010101:Oxygen Consumption; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use; D011437:Propylamines / Q000494:pharmacology* / Q000627:therapeutic use; D014648:Varicose Veins / Q000188:drug therapy; D014655:Vascular Resistance / Q000187:drug effects
D003508:Cycloheptanes; D005650:Fumarates; D010276:Parasympatholytics; D011437:Propylamines
Die Wirkung von Bencyclan auf die Blutdurchströmung der Extremitäten.